RNXT vs SO · rev $266.0K vs P/E 22, rev $29.55B
RenovoRx Inc (RNXT) versus Southern Company (SO) — a side-by-side from cached financials, not a winner call.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
Southern Company (SO) is a utilities - regulated electric company listed on US.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
Latest reported SO revenue for 2025-12-31 was $29.55B. Net income was $4.34B. Revenue was up 10.6% from 2024-12-31 to 2025-12-31. SO currently screens at market cap $101.55B and trailing P/E 22.1.
RNXT currently screens at market cap $47.0M. SO currently screens at market cap $101.55B and trailing P/E 22.1.
Not investment advice. Open the RNXT and SO stock pages for the full models.
Not investment advice.